Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
Nat Commun ; 12(1): 1467, 2021 03 05.
Article in English | MEDLINE | ID: covidwho-1118805

ABSTRACT

Efforts to contain the spread of SARS-CoV-2 have spurred the need for reliable, rapid, and cost-effective diagnostic methods which can be applied to large numbers of people. However, current standard protocols for the detection of viral nucleic acids while sensitive, require a high level of automation and sophisticated laboratory equipment to achieve throughputs that allow whole communities to be tested on a regular basis. Here we present Cap-iLAMP (capture and improved loop-mediated isothermal amplification) which combines a hybridization capture-based RNA extraction of gargle lavage samples with an improved colorimetric RT-LAMP assay and smartphone-based color scoring. Cap-iLAMP is compatible with point-of-care testing and enables the detection of SARS-CoV-2 positive samples in less than one hour. In contrast to direct addition of the sample to improved LAMP (iLAMP), Cap-iLAMP prevents false positives and allows single positive samples to be detected in pools of 25 negative samples, reducing the reagent cost per test to ~1 Euro per individual.


Subject(s)
COVID-19 Testing/methods , COVID-19/diagnosis , COVID-19/virology , Colorimetry/methods , Molecular Diagnostic Techniques/methods , Nucleic Acid Amplification Techniques/methods , Nucleic Acid Hybridization/methods , Point-of-Care Testing , SARS-CoV-2/isolation & purification , Coronavirus Nucleocapsid Proteins/genetics , Humans , Phosphoproteins/genetics , RNA, Viral/genetics , SARS-CoV-2/genetics , Sensitivity and Specificity
2.
PLoS One ; 15(12): e0244824, 2020.
Article in English | MEDLINE | ID: covidwho-1004472

ABSTRACT

SARS-CoV-2 causes substantial morbidity and mortality in elderly and immunocompromised individuals, particularly in retirement homes, where transmission from asymptomatic staff and visitors may introduce the infection. Here we present a cheap and fast screening method based on direct RT-qPCR to detect SARS-CoV-2 in single or pooled gargle lavages ("mouthwashes"). This method detects individuals with large viral loads (Ct≤29) and we use it to test all staff at a nursing home daily over a period of three weeks in order to reduce the risk that the infection penetrates the facility. This or similar approaches can be implemented to protect hospitals, nursing homes and other institutions in this and future viral epidemics.


Subject(s)
COVID-19 Nucleic Acid Testing , COVID-19 , Mass Screening , Real-Time Polymerase Chain Reaction , SARS-CoV-2/genetics , COVID-19/diagnosis , COVID-19/genetics , Humans
SELECTION OF CITATIONS
SEARCH DETAIL